Harvard Bioscience Inc. (HBIO) Fell -5.49% or -0.22 To Price $3.79 On Thursday


Harvard Bioscience Inc. (HBIO) fell -5.49% or -0.22 to $3.79. It is around 57842 shares traded, which is 42.66% compare to the average total volume 135595. The market cap of HBIO is $141.34 million. The year to date change is 19.83%. The 52 week price range is from $2.75 to $6.7. Price of HBIO have changed -0.25% during last week. It have changed 13.92% over last month, 7.80% over last 3 months, -28.39% over last 6 months and -15.13% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HBIO is 3.48. It is -8.18% below current price. The 200-day Moving Averages for HBIO is 4.53. It is 19.53% above current price. The 52-week High is 6.7. It is 76.78% from the current price. The 52-week Low is 2.75. It is -27.44% from current price.

There are some statistics of HBIO. It is has market cap $141.34 million. The share outstanding is 37.29 million. The average volume is 135595. The percent of top 15 Institution holding is 96.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HBIO is -4.25%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HBIO is -2.50%.


Tags:

Share this post